OCUL Stock Analysis: Buy, Sell, or Hold?
OCUL - Ocular Therapeutix, Inc.
$9.16
-0.34 (-3.58%)
▼
5d:
-5.08%
30d:
+3.39%
90d:
+3.15%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
OCUL is down 5.1% this week, but smart money is accumulating calls. Top strike: $10 2026-06-18 with 6,874 OI. Call ratio: 91% View Scanner →
Strength: 6.6/10
Get Alerted When OCUL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OCUL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OCUL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OCUL is currently trading at $9.16, which is considered fair relative to its 30-day fair value range of $8.81 to $9.69.
Technical Outlook: Technically, OCUL is in a strong uptrend. The price is currently testing key support at $8.94. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.00 (+183.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OCUL is in a strong uptrend. The price is currently testing key support at $8.94. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.00 (+183.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.81 -
$9.69
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
Holding OCUL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- BULLISH: Trading 183.8% below Wall St target ($26.00)
- CAUTION: Recommendation downgraded due to -5.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$8.81 -
$9.69
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$8.94
Resistance Level
$9.98
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.99
Wall Street Target
$26.00
(+183.8%)
Revenue Growth (YoY)
0.8%
Share & Embed Analysis
Last updated: May 18, 2026 8:42 AM ET
Data refreshes hourly during market hours. Next update: 9:42 AM
Data refreshes hourly during market hours. Next update: 9:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCUL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Peter Kaiser
SELL
2810 shares
2026-02-23
Pravin Dugel
SELL
20056 shares
2026-02-23
Sanjay Nayak
SELL
1759 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 60 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$181 | 61 BUY |
Advanced OCUL Option Strategies
Professional options setups generated by AI based on today's OCUL price and gamma walls.
